Ferrous fumarate

PreclinicalSmall molecule

GSK

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Iron Deficiency Anemia TreatmentRecruiting

Iron Deficiency Anemia TreatmentPreclinical

Recruiting

Timeline

Expected Milestones

Q1 2027

Phase 3Recruiting

Anemia

NCT07381426

Q4 2027

PreclinicalRecruiting

Iron Deficiency Anemia Treatment

NCT07014371

Clinical

Trials by Indication[1]

Iron deficiency anemia3 trials

Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women

Completed·—·Phase 3·NCT03212781·66 enrolled

Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

Completed·PPrince of Songkla University·Phase 3·NCT04130828·66 enrolled

Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women

Completed·HHatem AbuHashim·Phase 3·NCT03378791·120 enrolled

Anemia2 trials

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

Terminated·MMaastricht University Medical Center·Phase 4·NCT01975272·27 enrolled

Efficacy and Safety of Ferric Citrate in Iron Deficiency Anemia During the Second Trimester of Pregnancy in Bangladesh: A Randomized Controlled Trial

Recruiting·DDhaka Medical College·Phase 3·NCT07381426·680 enrolled

Efficacy and Safety2 trials

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

Terminated·OOrganon and Co·Phase 3·NCT01656434·3,173 enrolled

EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD

Unknown status·LLiverpool University Hospitals NHS Foundation Trust·Phase 3·NCT06321887·30 enrolled

Inflammatory Bowel Disease1 trial

Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease

Unknown status·LLeiden University Medical Center·Phase 4·NCT05456932·90 enrolled

Gastric1 trial

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass

Completed·RRijnstate Hospital·Phase 4·NCT02271997·120 enrolled

9 more indications

Complication1 trial

Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial

Unknown status·SSingapore General Hospital·Phase 4·NCT03295851·60 enrolled

Absorption1 trial

Iron Absorption Trial

Completed·RRijnstate Hospital·Phase 4·NCT02228902·24 enrolled

Treatment1 trial

Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia

Unknown status·—·Phase 4·NCT02243735·198 enrolled

Anti-inflammatory Therapy1 trial

Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.

Unknown status·LLeiden University Medical Center·N/A·NCT05581420·152 enrolled

Pregnant Women1 trial

The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.

Unknown status·MMartini Hospital Groningen·Phase 4·NCT05278793·58 enrolled

Cardiovascular Surgery1 trial

Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation

Completed·FFundación Canaria Rafael Clavijo para la Investigación Biomédica·Phase 4·NCT01078818·159 enrolled

Adult Subject1 trial

A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects

Completed· GSK logo

GSK·Phase 1·NCT01762995·24 enrolled

Iron Deficiency Anemia Treatment1 trial

Alternate-Day vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA): A Randomized, Open-Label, Non-Inferiority Trial

Recruiting·PPhramongkutklao College of Medicine and Hospital·Preclinical·NCT07014371·60 enrolled

Unspecified1 trial

Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 1·NCT00867867·235 enrolled

Sources

References

[1]
ClinicalTrials.gov — 18 trial records for Ferrous fumarate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ferrous fumarate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ferrous fumarate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GSK